专题:Pharmaceutical industry and healthcare

This cluster of papers explores the impact of pharmaceutical industry sponsorship on research outcome and quality, including conflicts of interest, financial ties between physicians and industry, direct-to-consumer advertising, publication bias, and ethical considerations in medical practice. The papers investigate the influence of funding sources on clinical trials, prescribing behavior, and the integrity of medical science.
最新文献
Advocacy capture of inference in policy-relevant health science: when moral commitments govern empirical claims

preprint Full Text OpenAlex

Adverse Events Associated with Clascoterone: A Real-World Pharmacovigilance Study of the Food and Drug Administration Adverse Event Reporting System

article Full Text OpenAlex

Peer Review of “Awareness, Experiences, and Attitudes Toward Preprints Among Medical Academics: Convergent Mixed Methods Study”

article Full Text OpenAlex

Peer Review of “Awareness, Experiences, and Attitudes Toward Preprints Among Medical Academics: Convergent Mixed Methods Study”

article Full Text OpenAlex

Palantir: NHS pilot’s “success” is questioned as second figure at major trust is linked to the tech giant

article Full Text OpenAlex

More transparency needed on misconduct

article Full Text OpenAlex

Industry Payments and Prescribing of Brand-Name Multiple Sclerosis Medications in Medicare

article Full Text OpenAlex

‘Most Favored Nation’ Drug Pricing Is An Idea Whose Time Has Come

article Full Text OpenAlex

BMA to ballot senior doctors on industrial action

article Full Text OpenAlex

Research integrity throughout the research lifecycle and stakeholders: Part 1 – A broad concept broken down

article Full Text OpenAlex

近5年高被引文献